From: Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
Molecular subtype
Metastatic organotropism
Features of BCSCs
Proportion
Molecular marker
Epithelial / Mesenchymal status
Luminal A
Bone [33]
Low
-
Luminal B
Bone, Liver [33, 34]
HER2 enriched
Lung, Brain, Liver [33]
High
ALDH+ [35,36,37]
Epithelial-like
Triple negative
Lung, Brain, Distant nodes [33]
CD24- CD44+ [35, 38, 39]
Mesenchymal-like [40]